These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2419975)

  • 1. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
    Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
    Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
    Nguyen CP; Cao VV; Fehér J; Gergely P
    Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levels of anti-nDNA using immunofluorescence on Crithidia luciliae. II. Prognostic value of complement-fixing anti-nDNA. Longitudinal study of 16 lupus disorders].
    Meyer O; Borda-Iriarte O; Cyna J; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):243-9. PubMed ID: 6377460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
    Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
    Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between clinical activity and serological markers in a wide cohort of patients with systemic lupus erythematosus: an eight-year prospective study.
    Villegas-Zambrano N; Martínez-Taboada VM; Bolívar A; San Martín M; Alvarez L; Marín MJ; López-Hoyos M
    Ann N Y Acad Sci; 2009 Sep; 1173():60-6. PubMed ID: 19758133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
    Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
    Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
    Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
    Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum autoantibodies in systemic lupus erythematosus and correlation with cutaneous features.
    Synkowski DR; Reichlin M; Provost TT
    J Rheumatol; 1982; 9(3):380-5. PubMed ID: 6981704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.
    Vallin H; Perers A; Alm GV; Rönnblom L
    J Immunol; 1999 Dec; 163(11):6306-13. PubMed ID: 10570325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases.
    Clarke MC; Carr R; Burdash NM; Chen ZY; Ainsworth SK
    Diagn Immunol; 1986; 4(6):288-93. PubMed ID: 3545632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns.
    Matsuki Y; Suzuki K; Kawakami M; Ishizuka T; Kawaguchi Y; Hidaka T; Nakamura H
    J Clin Apher; 1996; 11(1):30-5. PubMed ID: 8722720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus.
    Ludivico CL; Zweiman B; Myers AR; Hebert J; Green PA
    J Rheumatol; 1980; 7(6):843-9. PubMed ID: 6970815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus.
    Batteux F; Palmer P; Daëron M; Weill B; Lebon P
    Eur Cytokine Netw; 1999 Dec; 10(4):509-14. PubMed ID: 10586117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological aspects of pulse therapy in systemic lupus erythematosus].
    Nasonov EL; Solov'ev SK; Ivanova MM; Timofeeva EB; Lekakh IV
    Ter Arkh; 1986; 58(7):49-54. PubMed ID: 3764741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.